Is the prediction of prognosis not improved by the seventh edition of the TNM classification for colorectal cancer? Analysis of the surveillance, epidemiology, and end results (SEER) database

scientific article

Is the prediction of prognosis not improved by the seventh edition of the TNM classification for colorectal cancer? Analysis of the surveillance, epidemiology, and end results (SEER) database is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1036742137
P356DOI10.1186/1471-2407-13-123
P932PMC publication ID3651725
P698PubMed publication ID23496812
P5875ResearchGate publication ID236051235

P2093author name stringPeng Gao
Miao Yu
Hui-mian Xu
Jing-xu Sun
Lin-lin Tong
Ying-ying Xu
Yong-xi Song
Zhen-ning Wang
P2860cites workCancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deathsQ28241157
Revised TN categorization for colon cancer based on national survival outcomes dataQ33516922
Revised tumor and node categorization for rectal cancer based on surveillance, epidemiology, and end results and rectal pooled analysis outcomesQ33627785
Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition stagingQ33982101
Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errorsQ39605793
Is the seventh edition of the UICC/AJCC TNM staging system reasonable for patients with tumor deposits in colorectal cancer?Q43742675
Lymph nodes, tumor deposits, and TNM: are we getting better?Q43868593
Prediction of prognosis is not improved by the seventh and latest edition of the TNM classification for colorectal cancer in a single-center collectiveQ44296108
Analysis of the seventh edition of American Joint Committee on colon cancer stagingQ48791433
Bayesian information criterion for censored survival models.Q52118297
Revised staging: is it really better, or do we not know?Q53755343
Validation of the seventh edition of the American Joint Committee on Cancer tumor-node-metastasis (AJCC TNM) staging in patients with stage II and stage III colorectal carcinoma: analysis of 2511 cases from a medical centre in KoreaQ57226367
Current TNM staging of colorectal cancerQ80572839
A comparison of the new (planned) TNM classification and Japanese general rule for staging colorectal cancerQ84885032
P407language of work or nameEnglishQ1860
P921main subjectcolorectal cancerQ188874
P304page(s)123
P577publication date2013-03-17
P1433published inBMC CancerQ326300
P1476titleIs the prediction of prognosis not improved by the seventh edition of the TNM classification for colorectal cancer? Analysis of the surveillance, epidemiology, and end results (SEER) database
P478volume13

Reverse relations

cites work (P2860)
Q36696374A report of the frequency of colorectal carcinoma and involved lymph nodes in South-West Iran
Q42398672Case Report: Collision Tumour of Colon Leiomyosarcoma and Adenocarcinoma
Q37593956Combined detection of the expression of Nm23-H1 and p53 is correlated with survival rates of patients with stage II and III colorectal cancer
Q55071626Combined microsatellite instability and BRAF gene status as biomarkers for adjuvant chemotherapy in stage III colorectal cancer.
Q99608966ERCC overexpression associated with a poor response of cT4b colorectal cancer with FOLFOX-based neoadjuvant concurrent chemoradiation
Q36297989Effect of Lymph Node Count on Pathological Stage III Rectal Cancer with Preoperative Radiotherapy
Q35068085Increased number of negative lymph nodes is associated with improved cancer specific survival in pathological IIIB and IIIC rectal cancer treated with preoperative radiotherapy
Q51307767Koelreuteria Formosana Extract Induces Growth Inhibition and Cell Death in Human Colon Carcinoma Cells via G2/M Arrest and LC3-II Activation-Dependent Autophagy.
Q40312006Lymph Node Ratio as a Risk Factor for Recurrence After Adjuvant Chemotherapy in Stage III Colorectal Cancer.
Q36151978Lymph node count after preoperative radiotherapy is an independently prognostic factor for pathologically lymph node-negative patients with rectal cancer
Q64981746Lymph node ratio as a valuable prognostic factor for patients with colorectal liver-only metastasis undergoing curative resection.
Q37564560Over-expression of AURKA, SKA3 and DSN1 contributes to colorectal adenoma to carcinoma progression
Q36571451Overexpression of the S100A2 protein as a prognostic marker for patients with stage II and III colorectal cancer.
Q64063399Prognosis Prediction of Colorectal Cancer Using Gene Expression Profiles
Q47428842Prognostic Value of Clinical vs Pathologic Stage in Rectal Cancer Patients Receiving Neoadjuvant Therapy.
Q57485485Significance of lymph node metastasis in the survival of stage IV colorectal cancer by hematogenous metastasis
Q97525347Surgical management and hyperthermic intraperitoneal chemotherapy for locally advanced colorectal cancer
Q37683046TMPRSS4 correlates with colorectal cancer pathological stage and regulates cell proliferation and self-renewal ability
Q35024261Tumor deposit is a poor prognostic indicator in patients who underwent simultaneous resection for synchronous colorectal liver metastases
Q55408333Upregulation of c-mesenchymal epithelial transition expression and RAS mutations are associated with late lung metastasis and poor prognosis in colorectal carcinoma.

Search more.